2,112
Views
10
CrossRef citations to date
0
Altmetric
OBSTETRIC AND PERINATAL COMPLICATIONS IN PREGNANCIES ACHIEVED USING DONOR OOCYTES AND SINGLE ET

Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study

, , , , , & show all
Pages 314-319 | Received 08 May 2018, Accepted 23 Sep 2018, Published online: 09 Jan 2019

References

  • Dior UP, Laufer N, Chill HH, et al. Increased incidence of preeclampsia in mothers of advanced age conceiving by oocyte donation. Arch Gynecol Obstet 2018;297:1293–1299.
  • Ishihara O, Adamson GD, Dyer S, et al. International committee for monitoring assisted reproductive technologies: world report on assisted reproductive technologies, 2007. Fertil Steril. 2015;103:402–413.e11.
  • Pennings G, de Mouzon J, Shenfield F, et al. Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries. Hum Reprod. 2014;29:1076–1089.
  • ESHRE fact sheets 3. 2017 January – Egg donation. Available at: https://www.eshre.eu.
  • Qiao J, Feng HL. Assisted reproductive technology in China: compliance and non-compliance. Transl Pediatr. 2014;3:91–97.
  • Weissman A, Leong M, Sauer MV, Shoham Z. Characterizing the practice of oocyte donation: a web-based international survey. Reprod Biomed Online. 2014;28:443–450.
  • Storgaard M, Loft A, Bergh C, et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG. 2017;124:561–572.
  • Henne MB, Zhang M, Paroski S, et al. Comparison of obstetric outcomes in recipients of donor oocytes vs. women of advanced maternal age with autologous oocytes. J Reprod Med. 2007;52:585–590.
  • Malchau SS, Loft A, Larsen EC, et al. Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study. Fertil Steril. 2013;99:1637–1643.
  • Elenis E, Svanberg AS, Lampic C, et al. Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden. BMC Pregnancy Childbirth. 2015;15:247.
  • Krieg SA, Henne MB, Westphal LM. Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertil Steril. 2008;90:65–70.
  • Stoop D, Baumgarten M, Haentjens P, et al. Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod Biol Endocrinol. 2012;10:42.
  • Gibbons WE, Cedars M, Ness RB; Society for Assisted Reproductive Technologies Writing Group. Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis. Fertil Steril. 2011;95:1645–1649.e1.
  • Dude AM, Yeh JS, Muasher SJ. Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies. Fertil Steril. 2016;106:660–665.
  • Nejdet S, Bergh C, Kallen K, et al. High risks of maternal and perinatal complications in singletons born after oocyte donation. Acta Obstet Gynecol Scand. 2016;95:879–886.
  • Kamath MS, Antonisamy B, Mascarenhas M, Sunkara SK. High-risk of preterm birth and low birth weight after oocyte donation IVF: analysis of 133,785 live births. Reprod Biomed Online. 2017;35:318–324.
  • Karlström PO, Holte J, Hadziosmanovic N, et al. Does ovarian stimulation regimen affect IVF outcome? A two-centre, real-world retrospective study using predominantly cleavage-stage, single embryo transfer. Reprod Biomed Online. 2018;36:59–66.
  • Thurin A, Hausken J, Hillensjo T, et al. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization. N Engl J Med. 2004;351:2392–2402.
  • Petersson K, Persson M, Lindkvist M, et al. Internal validity of the Swedish Maternal Health Care Register. BMC Health Serv Res. 2014;30:364.
  • Marsal K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85:843–848.
  • Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–622.
  • Jaques AM, Amor DJ, Baker HW, et al. Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies. Fertil Steril. 2010;94:2674–2679.
  • Masoudian P, Nasr A, de Nanassy J, et al. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214:328–339.
  • Pecks U, Maass N, Neulen j. Oocyte Donation: A Risk Factor for Pregnancy-Induced Hypertension: A Meta-Analysis and Case Series. Dtsch Arztebl Int 2011;108:23–31.
  • van der Hoorn ML, Lashley EE, Bianchi DW, et al. Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update. 2010;16:704–712.
  • The Swedish National Board of Health and Welfare. Pregnancies, deliveries and newborns – The Medical Birth Registry 1973-2014 – Assisted Reproduction 1991-2013. (Graviditeter, förlossningar och nyfödda barn – Medicinska födelseregistret 1973–2014 – Assisterad befruktning 1991–2013). Available at: https://wwwsocialstyrelsense/publikationer2015/2015-12-27. 2015.